1 |
Afzal, M., Al-Hadidi, D., Menon, M., Pesek, J., and Dhami, M.S. (2001). Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol. Drug Interact. 18, 159-190
|
2 |
Doyle, S.L., and O'Neill, L.A. (2006). Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 72, 1102-1113
DOI
ScienceOn
|
3 |
Medzhitov, R., Preston-Hurlburt, P., and Janeway, C.A., Jr. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397
DOI
ScienceOn
|
4 |
Pan, M.H., Hsieh, M.C., Hsu, P.C., Ho, S.Y., Lai, C.S., Wu, H., Sang, S., and Ho, C.T. (2008). 6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Mol. Nutr. Food Res. 52, 1-11
|
5 |
Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K., and Akira, S. (2003). Toll/IL-1 receptor domaincontaining adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171, 4304-4310
DOI
|
6 |
Youn, H.S., Lee, J.Y., Fitzgerald, K.A., Young, H.A., Akira, S., and Hwang, D.H. (2005). Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175, 3339-3346
DOI
|
7 |
Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R.L., and Akira, S. (2002). Cutting edge: role of Tolllike receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10-14
DOI
|
8 |
Youn, H.S., Saitoh, S.I., Miyake, K., and Hwang, D.H. (2006b). Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem. Pharmacol. 72, 62-69
DOI
ScienceOn
|
9 |
Tao, X., Xu, Y., Zheng, Y., Beg, A.A., and Tong, L. (2002). An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2. Biochem. Biophys. Res. Commun. 299, 216-221
DOI
ScienceOn
|
10 |
Takeuchi, O., Kawai, T., Muhlradt, P.F., Morr, M., Radolf, J.D., Zychlinsky, A., Takeda, K., and Akira, S. (2001). Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13, 933-940
DOI
ScienceOn
|
11 |
Youn, H.S., Lim, H.J., Choi, Y.J., Lee, J.Y., Lee, M.Y., and Ryu, J.H. (2008a). Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists. Int. Immunopharmacol. 8, 495-501
DOI
ScienceOn
|
12 |
Takeda, K., and Akira, S. (2005). Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14
|
13 |
Chang, C.P., Chang, J.Y., Wang, F.Y., and Chang, J.G. (1995). The effect of Chinese medicinal herb Zingiberis rhizoma extract on cytokine secretion by human peripheral blood mononuclear cells. J. Ethnopharmacol. 48, 13-19
DOI
ScienceOn
|
14 |
Saitoh, S., Akashi, S., Yamada, T., Tanimura, N., Kobayashi, M., Konno, K., Matsumoto, F., Fukase, K., Kusumoto, S., Nagai, Y., et al. (2004). Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligandinduced TLR4 oligomerization. Int. Immunol. 16, 961-969
DOI
ScienceOn
|
15 |
Youn, H.S., Lee, J.K., Choi, Y.J., Saitoh, S.I., Miyake, K., Hwang, D.H., and Lee, J.Y. (2008b). Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem. Pharmacol. 75, 494-502
DOI
ScienceOn
|
16 |
Rhode, J., Fogoros, S., Zick, S., Wahl, H., Griffith, K.A., Huang, J., and Liu, J.R. (2007). Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement Altern Med. 7, 44
DOI
ScienceOn
|
17 |
Fitzgerald, K.A., McWhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E., Golenbock, D.T., Coyle, A.J., Liao, S.M., and Maniatis, T. (2003). IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496
DOI
ScienceOn
|
18 |
Surh, Y.J. (2002). Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem. Toxicol. 40, 1091-1097
DOI
ScienceOn
|
19 |
Kim, J.J., Ahn, S.I., Lee, J.S., Yun, S.M., Lee, M., and Youn, H.S. (2008). Suppression of the expression of cyclooxygenase-2 induced by Toll-like receptor 2, 3, and 4 agonists by 6-shogaol. Korean J. Food SCI Technol. 40, 332-336
|
20 |
Youn, H.S., Lee, J.Y., Saitoh, S.I., Miyake, K., Kang, K.W., Choi, Y.J., and Hwang, D.H. (2006a). Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)- epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem. Pharmacol. 72, 850-859
DOI
ScienceOn
|
21 |
Toshchakov, V., Jones, B.W., Perera, P.Y., Thomas, K., Cody, M.J., Zhang, S., Williams, B.R., Major, J., Hamilton, T.A., Fenton, M.J., et al. (2002). TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3, 392-398
DOI
ScienceOn
|
22 |
Takada, Y., Murakami, A., and Aggarwal, B.B. (2005). Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 24, 6957-6969
DOI
ScienceOn
|
23 |
Ippoushi, K., Azuma, K., Ito, H., Horie, H., and Higashio, H. (2003). [6]-Gingerol inhibits nitric oxide synthesis in activated J774.1 mouse macrophages and prevents peroxynitrite-induced oxidation and nitration reactions. Life Sci. 73, 3427-3437
DOI
ScienceOn
|
24 |
Youn, H.S., Lee, J.Y., Saitoh, S.I., Miyake, K., and Hwang, D.H. (2006c). Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Biochem. Biophys. Res. Commun. 350, 866-871
DOI
ScienceOn
|
25 |
Hajjar, A.M., O'Mahony, D.S., Ozinsky, A., Underhill, D.M., Aderem, A., Klebanoff, S.J., and Wilson, C.B. (2001). Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166, 15-19
DOI
|
26 |
Kim, S.O., Kundu, J.K., Shin, Y.K., Park, J.H., Cho, M.H., Kim, T.Y., and Surh, Y.J. (2005). [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene 24, 2558-2567
DOI
ScienceOn
|
27 |
Thomson, M., Al-Qattan, K.K., Al-Sawan, S.M., Alnaqeeb, M.A., Khan, I., and Ali, M. (2002). The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 67, 475-478
DOI
ScienceOn
|